4.6 Review

Huntington's disease: degradation of mutant huntingtin by autophagy

期刊

FEBS JOURNAL
卷 275, 期 17, 页码 4263-4270

出版社

WILEY
DOI: 10.1111/j.1742-4658.2008.06562.x

关键词

autophagy; Huntington's disease; lithium; mTOR; polyglutamine; rapamycin

资金

  1. Medical Research Council [G0600194] Funding Source: researchfish
  2. MRC [G0600194] Funding Source: UKRI
  3. Medical Research Council [G0600194, G0600194(77639)] Funding Source: Medline
  4. Wellcome Trust [064354] Funding Source: Medline

向作者/读者索取更多资源

Autophagy is a nonspecific bulk degradation pathway for long-lived cytoplasmic proteins, protein complexes, or damaged organelles. This process is also a major degradation pathway for many aggregate-prone, disease-causing proteins associated with neurodegenerative disorders, such as mutant huntingtin in Huntington's disease. In this review, we discuss factors regulating the degradation of mutant huntingtin by autophagy. We also report the growing list of new drugs/pathways that upregulate autophagy to enhance the clearance of this mutant protein, as autophagy upregulation may be a tractable strategy for the treatment of Huntington's disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据